eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Symptom | C2711227|hepatic steatosis |
| Sentences | 12 |
| PubMedID- 23733885 | Triglyceride (tg) accumulation in hepatocytes (hepatic steatosis) preludes the development of advanced nonalcoholic fatty liver diseases (naflds) such as steatohepatitis, fibrosis, and cirrhosis. |
| PubMedID- 21235825 | It has been reported that lifestyle intervention with diet and physical activity is effective at reducing hepatic steatosis in patients with non-alcoholic fatty liver disease . |
| PubMedID- 25802727 | It could be relevant that our patients showed only mild elevation of transaminase levels at baseline, given that glp-1 receptor agonists were associated with significant improvements in abnormal liver transaminases, biomarkers of hepatocytes, and hepatic steatosis in patients with non-alcoholic fatty liver disease in two human reports24,25. |
| PubMedID- 23022226 | In population studies hepatic steatosis in subjects with non-alcoholic fatty liver disease (nafld) is strongly associated with insulin resistance. |
| PubMedID- 21604917 | hepatic steatosis due to non-alcoholic fatty liver disease is associated with obesity, dyslipidemia, insulin resistance, and type 2 diabetes. |
| PubMedID- 24694249 | Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease. |
| PubMedID- 26524364 | Objective: to use a rat model of nonalcoholic liver disease (nafld) to observe effects of the peroxisome proliferator-activated receptor-a (ppar-a) agonist fenofibrate on hepatic steatosis in nonalcoholic fatty liver and to investigate the underlying mechanism. |
| PubMedID- 25455415 | A biochemical view: increase in polyunsaturated fatty acid omega-6/omega-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. |
| PubMedID- 21788761 | Background and aims: the diagnostic accuracy of hepatic ultrasonography (us) for detection and grading of hepatic steatosis in children with suspected nonalcoholic fatty liver disease (nafld) remains poorly characterized. |
| PubMedID- 26052340 | Background: diet-induced hepatic steatosis is highly associated with nonalcoholic fatty liver disease, which is related to the development of metabolic syndrome. |
| PubMedID- 25529941 | Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. |
| PubMedID- 20022466 | Objective: we evaluated the effect of diet therapy as exclusive treatment on insulin resistance, biochemical parameters of metabolic syndrome, and degree of hepatic steatosis in patients with non-alcoholic fatty liver disease. |
Page: 1